More about
Her2-Low Metastatic Breast Cancer
News
June 02, 2024
3 min read
Save
Trastuzumab deruxtecan improves PFS in pretreated breast cancer
CHICAGO — Trastuzumab deruxtecan extended PFS compared with standard chemotherapy for certain patients with pretreated breast cancer, according to findings presented at ASCO Annual Meeting.
News
February 26, 2024
5 min read
Save
Treatment landscape for metastatic breast cancer no longer in a ‘primitive place’
The treatment landscape for metastatic breast cancer has evolved tremendously within the past 2 decades.